FDA Approved: TALZENNA — Original Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved TALZENNA (talazoparib) as a single-agent treatment for adults with deleterious or suspected deleterious germline BRCA-mutated, HER2-negative locall…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Talzenna (talazoparib)

Snippet

ORIG AP for TALZENNA (TALAZOPARIB)